Abiopharma

🔍 Biebighauser Lon A. (Executive)

Company: FIRST FINANCIAL BANKSHARES INC (FFIN)

Report Date: 2026-08-14

Detailed Transactions and Holdings:

• Acquired 1,429 shares of Common Stock (Direct)
  Date: 2026-08-14 | Code: A | equity_swap_involved: false | shares_owned_after: 12,442.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 94 shares of Common Stock at $35.28 per share (Direct)
  Date: 2026-08-14 | Code: F | equity_swap_involved: false | shares_owned_after: 12,348.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 570 shares of Common Stock (Direct)
  Date: 2026-08-17 | Code: G | equity_swap_involved: false | shares_owned_after: 11,778.00 | transaction_form_type: 4
• Acquired 2,653 shares of Employee Stock Option, Right to Buy at $35.28 per share (Derivative)
  Date: 2026-08-14 | Code: A | Expires: 2036-08-14 | equity_swap_involved: false | shares_owned_after: 2,653.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Reflects grant of restricted stock units (RSUs) which vest in three approximately equal installments on each of the three anniversaries of the grant date.
• F2: The reporting person elected, in accordance with the Registrant's 2021 Omnibus Stock and Incentive Plan, to exercise his right to have the Registrant withhold 94 shares of the Registrant's common stock to pay income taxes related to vesting of previously granted restricted stock units.
• F3: The options vest 33.33% after one year from the grant date, 66.66% after the second year, and 100% after the third year.